玻璃体内注射贝伐单抗使新生血管性后囊膜血管消退。
Regression of neovascular posterior capsule vessels by intravitreal bevacizumab.
作者信息
Eren Ebru, Küçükerdönmez Cem, Yilmaz Gürsel, Akova Yonca A
机构信息
Department of Ophthalmology, Faculty of Medicine, Başkent University, 06490 Bahçelievler, Ankara, Turkey.
出版信息
J Cataract Refract Surg. 2007 Jun;33(6):1113-5. doi: 10.1016/j.jcrs.2007.01.040.
We present a 76-year-old woman who developed neovascularization of the posterior capsule 1 year after extracapsular cataract extraction. She had type 2 diabetes for 15 years, with proliferative diabetic retinopathy that had been treated with panretinal photocoagulation. The neovascular vessels on the posterior capsule originated from existing rubeosis iridis and regressed after a single injection of intravitreal bevacizumab (Avastin). The patient's visual acuity increased to 20/40 after an uneventful neodymium:YAG capsulotomy.
我们报告一名76岁女性，她在白内障囊外摘除术后1年出现后囊膜新生血管形成。她患2型糖尿病15年，伴有增殖性糖尿病视网膜病变，曾接受全视网膜光凝治疗。后囊膜上的新生血管起源于现有的虹膜红变，并在单次玻璃体腔内注射贝伐单抗（阿瓦斯汀）后消退。在顺利进行钕：钇铝石榴石激光晶状体后囊切开术后，患者视力提高到20/40。
Zotero 插件